Appeal No. 2001-0762 Page 6 Application No. 08/343,585 binding, which is required to provide the protein with it’s “honorary” enzymatic activity. Nevertheless, the examiner asserts (id.)” a person of ordinary skill in the art would reasonably expect that the all-D Ni2+ rubredoxin analog would exhibit the same hydrogenase- like activity discussed for the all-L Ni2+ rubredoxin in Zawadzke et al. (citing Saint-Martin …) as a result of the binding of Ni2+ to the coordinating site in the same manner in either all-D or all-L rubredoxin. However, as appellants point out, the facts in evidence dispute the examiner’s conclusion. According to appellants (Brief, page 8), Saint-Martin state “‘[a]t present it is difficult to establish a complete mechanism for hydrogen activation by the modified rubredoxins.” With regard to the rubredoxin isolate used by Zawadzke appellants argue that Saint-Martin state: This rubredoxin has the peculiarity of having the shortest amino acid polypeptide chain (45 amino acids instead of the 53 of the other two) but has one more cysteine (5 cysteine residues instead of 4) … These differences may be significant in the respective activities observed, but further experiments are necessary to assess the implication of these differences in the mechanism of activation of the hydrogen molecule by the modified Ni-rubredoxins. To support prima facie case of obviousness, the prior art relied upon must provide a person of ordinary skill in the art with a reasonable expectation of success. In re Vaeck, 947 F.2d 488, 493, 20 USPQ2d 1438, 1442 (Fed. Cir. 1991). Based on the evidence of record, and in contrast to the examiner’s position, we are compelled to agree with appellants (Brief, page 9) that one of ordinary skill in the art at the time the invention was made would not have believed that the changes between the native and analog rubredoxins were minor with respect to its hydrogenase activity, or that it could be reasonably expected that Zawadzke’s modified rubredoxin would have had the hydrogenasePage: Previous 1 2 3 4 5 6 7 8 NextLast modified: November 3, 2007